open access

Vol 3, No 1 (2014)
Review articles (submitted)
Published online: 2014-03-03
Get Citation

Safety of oral incretin treatment

Marta Wróbel, Aleksandra Szymborska-Kajanek, Dominika Rokicka, Magdalena Girek-Bączewska, Krzysztof Strojek, Krzysztof Strojek
Diabetologia Kliniczna 2014;3(1):31-37.

open access

Vol 3, No 1 (2014)
Review articles (submitted)
Published online: 2014-03-03

Abstract

Incretin therapy has been used in line with currentguidance in treatment of type 2 diabetes for a fewyears. The efficacy of incretin mimetics and incretinenhancers has been proved in many clinical studiesso far. Since this therapy is available on market thereare concerns regarding its safety. This article is an reviewof current data about safety of DPP-4 inhibitorsin special groups of patients: elderly, prone to hypoglycemia,or with deterioration of kidney function. Itconcerns also on issues associated with cardiovascularrisk, pancreatitis and pancreatic cancer.

Abstract

Incretin therapy has been used in line with currentguidance in treatment of type 2 diabetes for a fewyears. The efficacy of incretin mimetics and incretinenhancers has been proved in many clinical studiesso far. Since this therapy is available on market thereare concerns regarding its safety. This article is an reviewof current data about safety of DPP-4 inhibitorsin special groups of patients: elderly, prone to hypoglycemia,or with deterioration of kidney function. Itconcerns also on issues associated with cardiovascularrisk, pancreatitis and pancreatic cancer.

Get Citation

Keywords

diabetes, incretin therapy, DPP-4 inhibitors, safety

About this article
Title

Safety of oral incretin treatment

Journal

Clinical Diabetology

Issue

Vol 3, No 1 (2014)

Pages

31-37

Published online

2014-03-03

Bibliographic record

Diabetologia Kliniczna 2014;3(1):31-37.

Keywords

diabetes
incretin therapy
DPP-4 inhibitors
safety

Authors

Marta Wróbel
Aleksandra Szymborska-Kajanek
Dominika Rokicka
Magdalena Girek-Bączewska
Krzysztof Strojek
Krzysztof Strojek

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl